Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen recept...
Q1 2026
May 12, 2026
FY 2025
Mar 16, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 11, 2025